| 1.2 |
3.7 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.1 |
3.4 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 1.1 |
5.5 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.1 |
3.3 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 1.1 |
6.3 |
GO:0071499 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 1.0 |
3.1 |
GO:0030421 |
defecation(GO:0030421) |
| 1.0 |
4.1 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 1.0 |
1.0 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.9 |
5.6 |
GO:0042160 |
lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.9 |
0.9 |
GO:1901145 |
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
| 0.9 |
3.6 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.8 |
2.4 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.7 |
0.7 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.7 |
2.2 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.7 |
2.2 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.7 |
2.1 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.7 |
0.7 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.7 |
2.0 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.7 |
2.7 |
GO:0072235 |
distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
| 0.7 |
2.7 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.7 |
0.7 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.7 |
2.6 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.7 |
0.7 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.6 |
1.9 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.6 |
1.9 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.6 |
2.5 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.6 |
3.8 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.6 |
2.4 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.6 |
1.2 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 0.6 |
2.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.6 |
1.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.6 |
1.7 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.6 |
1.1 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.6 |
3.3 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.6 |
2.2 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.5 |
0.5 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.5 |
1.6 |
GO:0048818 |
positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) |
| 0.5 |
2.1 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.5 |
1.5 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.5 |
3.1 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
1.0 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.5 |
0.5 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.5 |
2.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.5 |
4.0 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 |
1.5 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 |
3.9 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.5 |
1.5 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.5 |
1.5 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.5 |
1.0 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.5 |
1.4 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 |
1.4 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.5 |
1.8 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.5 |
1.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.5 |
0.5 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.5 |
2.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.4 |
1.8 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 |
1.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.4 |
1.8 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.4 |
0.9 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.4 |
1.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.4 |
1.3 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.4 |
1.3 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.4 |
0.9 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.4 |
1.7 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.4 |
2.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 |
1.3 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.4 |
1.7 |
GO:0003180 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.4 |
1.2 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.4 |
2.1 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.4 |
1.2 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 |
0.8 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.4 |
2.5 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.4 |
2.9 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.4 |
2.4 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.4 |
1.2 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 0.4 |
0.8 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.4 |
0.8 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.4 |
2.4 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.4 |
1.2 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 |
0.8 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.4 |
1.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.4 |
1.5 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.4 |
4.2 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.4 |
0.4 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.4 |
1.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 |
1.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.4 |
2.6 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.4 |
1.5 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 |
1.1 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.4 |
1.8 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.4 |
1.5 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.4 |
0.4 |
GO:0060192 |
negative regulation of lipase activity(GO:0060192) |
| 0.4 |
0.4 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.4 |
2.2 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.4 |
0.4 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 0.4 |
2.9 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.4 |
0.7 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.4 |
2.8 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.3 |
0.3 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.3 |
1.0 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.3 |
1.0 |
GO:1903273 |
regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
| 0.3 |
0.7 |
GO:0072239 |
metanephric glomerulus vasculature development(GO:0072239) |
| 0.3 |
0.3 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 |
0.7 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.3 |
1.0 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.3 |
0.3 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 0.3 |
0.7 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.3 |
3.7 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.3 |
1.0 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.3 |
1.0 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.3 |
1.0 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.3 |
1.0 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 |
0.3 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 |
1.3 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.3 |
1.0 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 |
0.3 |
GO:0048819 |
regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) |
| 0.3 |
2.3 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.3 |
1.0 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.3 |
4.3 |
GO:0021514 |
ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.3 |
1.0 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 |
1.6 |
GO:0009227 |
nucleotide-sugar catabolic process(GO:0009227) |
| 0.3 |
0.6 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 |
0.6 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.3 |
1.0 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.3 |
0.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 |
1.0 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.3 |
1.0 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.3 |
1.3 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 |
0.9 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.3 |
1.6 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 |
0.9 |
GO:0072079 |
nephron tubule formation(GO:0072079) |
| 0.3 |
0.9 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.3 |
3.4 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.3 |
2.2 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 |
1.2 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.3 |
0.9 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 |
0.6 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.3 |
0.9 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.3 |
1.5 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.3 |
2.1 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.3 |
1.8 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.3 |
0.9 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.3 |
1.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.3 |
1.5 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.3 |
1.2 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.3 |
1.2 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.3 |
2.1 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.3 |
0.3 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.3 |
1.8 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.3 |
1.2 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.3 |
0.3 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
0.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.3 |
1.4 |
GO:0021938 |
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.3 |
0.9 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.3 |
3.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.3 |
0.3 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 0.3 |
1.1 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.3 |
0.6 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.3 |
0.3 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.3 |
1.1 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.3 |
0.8 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.3 |
3.0 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.3 |
0.8 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.3 |
0.8 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.3 |
0.5 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.3 |
0.5 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.3 |
1.3 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.3 |
1.1 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 |
1.6 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.3 |
0.3 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 |
0.8 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.3 |
0.8 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.3 |
1.0 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 |
2.6 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.3 |
1.0 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.3 |
0.8 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
0.8 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.3 |
0.8 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.3 |
1.0 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.3 |
0.5 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.3 |
0.5 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.3 |
0.3 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) |
| 0.3 |
0.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.2 |
0.2 |
GO:0002034 |
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.2 |
1.2 |
GO:0045989 |
positive regulation of striated muscle contraction(GO:0045989) |
| 0.2 |
3.2 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.2 |
0.5 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
1.2 |
GO:1901679 |
nucleotide transmembrane transport(GO:1901679) |
| 0.2 |
0.7 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.2 |
1.2 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 |
1.5 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.2 |
0.7 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.2 |
1.9 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 |
0.5 |
GO:0060051 |
negative regulation of protein glycosylation(GO:0060051) |
| 0.2 |
1.2 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
0.2 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.2 |
3.1 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.2 |
1.2 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
0.7 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.2 |
0.7 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.2 |
0.9 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.2 |
3.9 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.2 |
0.9 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
2.1 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.2 |
0.7 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
1.2 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
0.7 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.2 |
0.7 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
0.2 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.2 |
0.2 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.2 |
0.2 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.2 |
0.9 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.2 |
0.7 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.2 |
0.7 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.2 |
1.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 |
0.5 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.2 |
1.6 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
0.7 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.2 |
0.7 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.2 |
0.9 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
3.8 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.2 |
0.9 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 |
0.4 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.2 |
0.4 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
1.5 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.2 |
2.0 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.2 |
0.7 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.2 |
0.9 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.2 |
0.9 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.2 |
2.4 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.2 |
1.3 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.2 |
4.8 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.2 |
0.7 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
1.5 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.2 |
0.6 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.2 |
1.3 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 |
2.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
0.6 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.2 |
0.4 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.2 |
1.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.2 |
0.2 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 |
2.3 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.2 |
0.6 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.2 |
0.2 |
GO:0021889 |
olfactory bulb interneuron differentiation(GO:0021889) |
| 0.2 |
0.6 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.2 |
0.6 |
GO:0042977 |
activation of JAK2 kinase activity(GO:0042977) |
| 0.2 |
2.0 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.2 |
0.6 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.2 |
0.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.2 |
0.2 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.2 |
1.2 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.2 |
1.0 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 |
0.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 |
0.4 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.2 |
3.3 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.2 |
0.6 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 |
0.6 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.2 |
0.2 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 |
1.3 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.2 |
1.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 |
1.7 |
GO:0035947 |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.2 |
1.3 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
0.2 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.2 |
0.4 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.2 |
0.8 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.2 |
0.2 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.2 |
0.7 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
0.6 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.2 |
0.7 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
0.6 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) pancreas morphogenesis(GO:0061113) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.2 |
0.7 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.2 |
0.7 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.2 |
0.7 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 |
0.7 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 |
0.4 |
GO:0033628 |
regulation of cell adhesion mediated by integrin(GO:0033628) |
| 0.2 |
0.4 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 0.2 |
1.8 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.2 |
0.7 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.2 |
0.2 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
0.5 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) regulation of neuromuscular junction development(GO:1904396) positive regulation of neuromuscular junction development(GO:1904398) |
| 0.2 |
0.4 |
GO:0007442 |
hindgut morphogenesis(GO:0007442) |
| 0.2 |
0.4 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.2 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 |
0.5 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.2 |
1.4 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.2 |
0.7 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
0.4 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.2 |
0.9 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.2 |
0.4 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 |
0.5 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 |
0.7 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.2 |
2.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.2 |
1.1 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.2 |
0.4 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 |
1.6 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 |
1.9 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.2 |
0.7 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
0.7 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.2 |
0.5 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 |
0.7 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
0.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
0.7 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.2 |
0.3 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.2 |
1.4 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.2 |
0.7 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 |
6.1 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.2 |
0.7 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.2 |
0.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
0.8 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
1.0 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 |
0.2 |
GO:0034392 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.2 |
1.2 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.2 |
1.3 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 |
0.7 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.2 |
1.2 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
0.5 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
0.3 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.2 |
1.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.2 |
1.0 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.2 |
0.2 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.2 |
0.2 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.2 |
2.3 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.2 |
0.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.2 |
0.5 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.2 |
0.3 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.2 |
0.2 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.2 |
0.6 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.2 |
0.6 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.2 |
0.8 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.2 |
0.8 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
0.8 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.2 |
0.8 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
0.2 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.2 |
0.5 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
0.6 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
0.2 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.2 |
0.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
0.2 |
GO:1905155 |
regulation of phagocytosis, engulfment(GO:0060099) positive regulation of phagocytosis, engulfment(GO:0060100) regulation of membrane invagination(GO:1905153) positive regulation of membrane invagination(GO:1905155) |
| 0.2 |
0.5 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.2 |
0.2 |
GO:0033688 |
regulation of osteoblast proliferation(GO:0033688) |
| 0.2 |
0.8 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.2 |
0.6 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.2 |
1.1 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.2 |
1.1 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 |
0.6 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.2 |
0.2 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 |
0.6 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 |
0.6 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.1 |
0.6 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.1 |
0.4 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.1 |
0.6 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.1 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
0.7 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.7 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 |
0.9 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
1.0 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 |
0.7 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
0.9 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.7 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.3 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) linoleic acid metabolic process(GO:0043651) |
| 0.1 |
0.3 |
GO:1990414 |
cellular response to camptothecin(GO:0072757) replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 |
0.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
1.7 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.6 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
0.3 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.1 |
0.4 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 |
0.4 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
0.4 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.1 |
1.0 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.4 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.1 |
1.4 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.1 |
0.7 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
1.0 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.1 |
0.4 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) negative regulation of t-circle formation(GO:1904430) |
| 0.1 |
0.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.5 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.1 |
0.5 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.4 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.7 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.1 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.1 |
0.5 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
1.2 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
0.4 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.1 |
0.7 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.1 |
0.9 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.4 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.1 |
0.8 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.9 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.5 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.1 |
0.6 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.5 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.3 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.4 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 |
0.1 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.1 |
1.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.6 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.1 |
0.1 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.3 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.1 |
1.0 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.1 |
0.4 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 |
1.9 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.4 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.4 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
| 0.1 |
0.2 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 |
1.0 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
1.0 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
0.2 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.1 |
0.1 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.1 |
0.6 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.2 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 |
0.2 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.5 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.1 |
0.5 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.1 |
0.1 |
GO:0086017 |
corticospinal neuron axon guidance(GO:0021966) Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.1 |
5.3 |
GO:0043487 |
regulation of RNA stability(GO:0043487) |
| 0.1 |
0.2 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
1.5 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
0.5 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 |
1.2 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.1 |
1.7 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
0.4 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.5 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 |
1.2 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.1 |
0.6 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 |
0.8 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.5 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.1 |
1.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
1.2 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.1 |
GO:0015874 |
norepinephrine transport(GO:0015874) |
| 0.1 |
2.9 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.9 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.3 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 |
1.0 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.3 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 |
0.9 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.3 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.5 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.7 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.5 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
1.1 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.1 |
0.3 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.1 |
1.6 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.3 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.1 |
0.1 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.1 |
0.5 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.6 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.1 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 |
0.8 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.1 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.1 |
0.9 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
0.4 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 |
0.3 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 |
0.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.2 |
GO:0072033 |
renal vesicle formation(GO:0072033) |
| 0.1 |
1.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.6 |
GO:0046864 |
retinol transport(GO:0034633) nose morphogenesis(GO:0043585) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.1 |
0.6 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.4 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 |
1.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
3.8 |
GO:1902668 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.1 |
0.1 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.1 |
1.0 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.1 |
0.3 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.2 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.2 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.2 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 |
0.3 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.1 |
1.1 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.9 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
3.6 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 |
0.3 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.6 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
0.3 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
1.9 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
0.4 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.1 |
0.4 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.2 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.1 |
0.2 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.1 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
1.5 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 |
0.6 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.2 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 0.1 |
0.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.9 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.6 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
0.2 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.1 |
0.3 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 |
0.4 |
GO:0045625 |
regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.1 |
0.3 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.1 |
1.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.6 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.2 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.1 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) |
| 0.1 |
0.2 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.1 |
0.3 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
0.4 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.1 |
0.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.8 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
1.0 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 |
0.7 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.2 |
GO:1903726 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) negative regulation of phospholipid metabolic process(GO:1903726) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.1 |
3.0 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.8 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.1 |
0.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
3.0 |
GO:0071347 |
cellular response to interleukin-1(GO:0071347) |
| 0.1 |
0.2 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
1.0 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.5 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 |
0.3 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.8 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.4 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
1.3 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.1 |
0.8 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.1 |
0.7 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
0.1 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.1 |
0.2 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.5 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.1 |
1.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.6 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.3 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
0.2 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.1 |
0.2 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
0.3 |
GO:0072273 |
mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) metanephric nephron morphogenesis(GO:0072273) |
| 0.1 |
0.4 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.7 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.1 |
0.2 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 |
0.6 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.1 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.1 |
0.7 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.3 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.1 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
3.7 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
0.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.3 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.4 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.3 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.1 |
0.5 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.5 |
GO:0071281 |
cellular response to iron ion(GO:0071281) |
| 0.1 |
0.4 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.3 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 |
0.2 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 |
0.4 |
GO:0042435 |
indole-containing compound biosynthetic process(GO:0042435) |
| 0.1 |
0.3 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
1.6 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.1 |
0.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
1.5 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.2 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.1 |
0.3 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.2 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
0.5 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.1 |
0.3 |
GO:0045738 |
negative regulation of DNA repair(GO:0045738) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.1 |
0.3 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 |
0.1 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
0.3 |
GO:0071910 |
determination of liver left/right asymmetry(GO:0071910) |
| 0.1 |
0.2 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.2 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.7 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.1 |
0.3 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
1.1 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.1 |
0.3 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 |
0.1 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.1 |
0.3 |
GO:1901858 |
regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.1 |
0.1 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.1 |
0.6 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
0.4 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.1 |
0.2 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 0.1 |
0.2 |
GO:0098661 |
inorganic anion transmembrane transport(GO:0098661) |
| 0.1 |
0.2 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.1 |
0.8 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.1 |
0.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
0.7 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.2 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.2 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.1 |
0.1 |
GO:0099623 |
regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
| 0.1 |
0.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.5 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.1 |
GO:0009996 |
negative regulation of cell fate specification(GO:0009996) |
| 0.1 |
0.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
0.2 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.1 |
0.5 |
GO:0072575 |
hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
| 0.1 |
0.5 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.1 |
0.3 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.1 |
0.3 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
0.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.2 |
GO:1903909 |
regulation of receptor clustering(GO:1903909) |
| 0.1 |
0.2 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.1 |
0.1 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.4 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
0.4 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.3 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.4 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
1.6 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
0.4 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.1 |
GO:0043516 |
regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.1 |
0.2 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.5 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.8 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.6 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.6 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
1.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.3 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.1 |
0.5 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.1 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.1 |
0.2 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.1 |
0.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.1 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.1 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.5 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
0.2 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.1 |
0.3 |
GO:0046135 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 |
0.1 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.1 |
0.2 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
0.1 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 |
0.9 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.1 |
0.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.6 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.1 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 |
0.1 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.1 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
0.1 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.1 |
1.9 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
1.1 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.1 |
0.7 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.1 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.2 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.1 |
0.2 |
GO:0015868 |
purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.1 |
0.3 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
0.4 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.2 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.1 |
0.1 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) |
| 0.1 |
0.8 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.6 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.5 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.2 |
GO:0034476 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.1 |
0.3 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 |
0.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 |
0.3 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.8 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.3 |
GO:1902624 |
positive regulation of neutrophil migration(GO:1902624) |
| 0.1 |
1.4 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.1 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.5 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 |
0.2 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
1.0 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
1.0 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.5 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.1 |
0.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.2 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.7 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 |
0.2 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.1 |
0.1 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.1 |
0.3 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) glyoxylate metabolic process(GO:0046487) |
| 0.1 |
0.4 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
| 0.1 |
0.4 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.8 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.1 |
GO:1904238 |
pericyte cell differentiation(GO:1904238) |
| 0.1 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.1 |
GO:1903393 |
positive regulation of adherens junction organization(GO:1903393) |
| 0.1 |
0.5 |
GO:0006402 |
mRNA catabolic process(GO:0006402) |
| 0.1 |
0.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.1 |
0.4 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.1 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.6 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 |
0.3 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.1 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.1 |
0.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
0.9 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 |
1.1 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.1 |
0.6 |
GO:0060973 |
cell migration involved in heart development(GO:0060973) |
| 0.1 |
0.3 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.1 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centriole replication(GO:0046600) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
0.6 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.3 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.3 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.1 |
GO:2000152 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.4 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 |
1.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
0.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.2 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.2 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.1 |
0.1 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 |
0.1 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 |
0.2 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.1 |
0.4 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.2 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.1 |
0.2 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.1 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.1 |
0.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.1 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.1 |
0.4 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.1 |
0.8 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.1 |
0.1 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
0.5 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.2 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.1 |
GO:0060264 |
regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.1 |
0.1 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.1 |
0.2 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.1 |
0.1 |
GO:0072061 |
collecting duct development(GO:0072044) inner medullary collecting duct development(GO:0072061) |
| 0.1 |
0.3 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.1 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.0 |
0.2 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.6 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.1 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.0 |
0.4 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
1.5 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.1 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 |
1.7 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.3 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.0 |
0.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.0 |
0.1 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 |
1.5 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.0 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.0 |
0.3 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.0 |
0.7 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 |
0.4 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.0 |
0.3 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.1 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.0 |
0.1 |
GO:0022410 |
circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.0 |
0.5 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 |
1.4 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
1.2 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.2 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.5 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.6 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.1 |
GO:0042228 |
interleukin-8 biosynthetic process(GO:0042228) |
| 0.0 |
0.1 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.0 |
0.1 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 |
0.6 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.0 |
0.3 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 |
0.2 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.6 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.0 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.0 |
0.5 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.2 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.0 |
0.0 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 |
1.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 |
0.0 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.0 |
0.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 |
0.2 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.0 |
0.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.0 |
0.2 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.0 |
0.5 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.2 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 |
0.2 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
0.1 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.1 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.0 |
0.1 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.0 |
0.2 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.1 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.3 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.3 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.0 |
0.2 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.1 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 |
0.7 |
GO:1901663 |
quinone biosynthetic process(GO:1901663) |
| 0.0 |
1.3 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.7 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.2 |
GO:0071107 |
response to parathyroid hormone(GO:0071107) |
| 0.0 |
0.4 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.0 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.1 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.0 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.0 |
0.0 |
GO:1900424 |
regulation of defense response to bacterium(GO:1900424) |
| 0.0 |
0.4 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.0 |
GO:0042743 |
hydrogen peroxide metabolic process(GO:0042743) |
| 0.0 |
0.2 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.0 |
1.4 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.3 |
GO:0045624 |
positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.0 |
0.1 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.0 |
0.3 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.0 |
0.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.2 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.4 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.5 |
GO:0009410 |
response to xenobiotic stimulus(GO:0009410) |
| 0.0 |
0.1 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.0 |
0.2 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.1 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.0 |
0.0 |
GO:0009838 |
abscission(GO:0009838) negative regulation of cytokinesis(GO:0032466) |
| 0.0 |
0.2 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.0 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
1.2 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.0 |
0.0 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.2 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.3 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.1 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.0 |
0.0 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.0 |
0.3 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.0 |
0.4 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.3 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.0 |
0.1 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 |
0.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 |
0.4 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.1 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) |
| 0.0 |
0.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.2 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.4 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
0.1 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.0 |
0.5 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.1 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.0 |
0.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.4 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 |
0.1 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.1 |
GO:0044786 |
cell cycle DNA replication(GO:0044786) |
| 0.0 |
0.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 |
0.2 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 |
0.9 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.0 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.2 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.1 |
GO:0031063 |
regulation of histone deacetylation(GO:0031063) |
| 0.0 |
0.8 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.3 |
GO:0090342 |
regulation of cell aging(GO:0090342) |
| 0.0 |
0.5 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.3 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.1 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.0 |
0.1 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.0 |
0.1 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.2 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.0 |
1.0 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 |
0.0 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.2 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.0 |
0.1 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.3 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.0 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.1 |
GO:0060872 |
semicircular canal development(GO:0060872) |
| 0.0 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.0 |
0.1 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.0 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.0 |
2.1 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.0 |
0.5 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.0 |
0.2 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.0 |
0.1 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.0 |
0.1 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.0 |
0.1 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.0 |
0.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
0.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.0 |
0.0 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 |
0.0 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 |
0.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.1 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.0 |
0.1 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 |
1.0 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
0.2 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.0 |
0.3 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.3 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.0 |
0.1 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.1 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.3 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.1 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.0 |
0.1 |
GO:0045979 |
positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
| 0.0 |
0.6 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.0 |
0.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.0 |
0.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.1 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 |
0.0 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.0 |
0.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.1 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.1 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
0.1 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 |
0.0 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.0 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.0 |
0.1 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
0.1 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.0 |
0.1 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.2 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.0 |
0.1 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.1 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.2 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.0 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 0.0 |
0.0 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.0 |
0.1 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.0 |
0.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.0 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.3 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.2 |
GO:2000480 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.0 |
0.2 |
GO:1902692 |
regulation of neuroblast proliferation(GO:1902692) |
| 0.0 |
0.2 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.2 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.0 |
0.3 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.3 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 |
0.7 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.0 |
0.0 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of glycoprotein metabolic process(GO:1903019) |
| 0.0 |
0.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
| 0.0 |
0.1 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 |
0.0 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.0 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.1 |
GO:0051187 |
cofactor catabolic process(GO:0051187) |
| 0.0 |
0.1 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 |
0.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.1 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.0 |
0.1 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.0 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.0 |
0.0 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.0 |
0.0 |
GO:0090192 |
positive regulation of glomerular mesangial cell proliferation(GO:0072126) regulation of glomerulus development(GO:0090192) |
| 0.0 |
0.2 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.0 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.0 |
0.0 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.1 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
0.0 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) |
| 0.0 |
0.0 |
GO:0032309 |
icosanoid secretion(GO:0032309) icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
| 0.0 |
0.1 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.1 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.0 |
0.1 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.0 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.1 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.3 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.0 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.0 |
0.2 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.0 |
0.0 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.0 |
0.1 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.0 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.1 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.0 |
0.0 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.0 |
0.0 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.0 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.0 |
1.0 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.1 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.0 |
0.0 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.0 |
0.1 |
GO:0090151 |
establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.0 |
1.3 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.0 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.1 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
0.0 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.0 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.0 |
0.0 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.0 |
0.3 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
0.4 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.0 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.0 |
0.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.0 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.4 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.0 |
0.3 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.0 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.2 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.0 |
0.0 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.0 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 |
0.0 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.3 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.0 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 |
0.1 |
GO:0048524 |
positive regulation of viral process(GO:0048524) |
| 0.0 |
0.0 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.2 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.0 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 |
0.0 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.0 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.2 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.0 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
0.1 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.0 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.1 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.0 |
0.0 |
GO:1903798 |
regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
| 0.0 |
0.0 |
GO:0016114 |
terpenoid biosynthetic process(GO:0016114) |
